8:30 –  9:30  Registration and coffee

9:30 – 11:00 Session 1

Background

Maarit Venermo, Finland

ESVS Guidelines - any news, any controversies?

Henrik Sillesen, Denmark

Asymptomatic carotid stenosis is best managed medically

Lars Lönn and
Torben V Schroeder, Denmark

Accurcy of noninvasive imaging (US, CTA and MRA) is questioned, but does it matter clinically in the individual patient?

11:00 – 11:30 Coffee

11:30 – 13:00 Session 2

Perioperative considerations

Grethe Andersen, Denmark

Is preprocedural neurological assessment mandatory? Does it delay treatment? Should a symptomatic lesion be managed as being asymptomatic after 12 weeks?

Jan Brunkwall, Germany

Is intraprocedural cerebral monitoring necessary, and if how is it done best?

Derk W Krieger, Denmark

Is there indication for urgent revascularisation in neurological unstable patients?

13:00 – 13:45 Lunch

13:45 – 15:15 Session 3

Carotid surgery and angioplasty

Matt Thompson, UK

Which patients benefit most from surgery: Range of stenosis (incl near occlusion), age and gender

Bo Norrving, Sweden

Which patients benefit most from surgery: Symptomatology and timing

Hans-Henning Eckstein, Germany

Is carotid artery stenting still an alternative to surgery?

15:15 – 15:30 Coffee

15:30 – 17:00 Session 4

Quality and the future

Leif Panduro Jensen, Denmark

Quality assessment in carotid surgery: Does a vascular surgical registry provide the information? Does volume affect outcome?

Clark J Zeebregts,
  The Netherlands

Will molecular imaging (e.g. HR-MRI, SPECT, PET and NIRF) finally allow us to identify the vulnerable plaque for better selection of patients for carotid surgery?

A Ross Naylor, UK

Which questions may be answered by the upcoming trials - and which will remain unanswered?

19:00 Dinner

Restaurant Sans Souci